This Mukul Agrawal stock, engaged in operating multi-specialty hospitals providing advanced healthcare services, including medical, surgical, and trauma care across several specialties, is in focus after Vijay Kishanlal Kedia bought a 1 percent fresh stake in the company.
With a market capitalization of Rs. 7,972.36 crore, the shares of Yatharth Hospital & Trauma Care Services Limited were currently trading at Rs. 827.40 per equity share, rising nearly 0.52 percent from its previous day’s close price of Rs. 823.10.
What is the news?
In September 2025, Yatharth Hospital & Trauma Care Services Limited had a majority stake held by the promoters at 61.64 percent, foreign institutional investors at 6.51 percent, domestic institutional investors at 8.71 percent, and the public at 23.16 percent.
According to the NSE data, Ace Investor Vijay Kishanlal Kedia bought a fresh stake in the company through Kedia Securities Private Limited in September 2025 by acquiring approximately 9.65 lakh equity shares, equivalent to a 1 percent stake in Yatharth Hospital & Trauma Care Services Limited. The current holding value of his investment amounts to Rs. 79.8 crore.
Ace Investor Mukul Mahavir Agrawal is already holding approximately 11 lakh equity shares, equivalent to a 1.14 percent stake in Yatharth Hospital & Trauma Care Services Limited. The current holding value of his investment amounts to Rs. 91 crore. The presence of such famous ace investors highlights strong confidence and growth potential in Yatharth Hospital’s business.
Company Overview
Yatharth Hospital & Trauma Care Services Limited was incorporated in 2008 andis engaged in operating a chain of super specialty hospitals mainly in the Delhi NCR region, including locations in Noida, Greater Noida, and Noida Extension, Uttar Pradesh.
The hospital is engaged in delivering specialized medical care through multiple centers of excellence covering medicine, surgery, cardiology, neurology, nephrology, orthopedics, pediatrics, and more.
Yatharth Hospital & Trauma Care Services Limited operates 7 hospitals and has 11 Centers of Excellence, with 87 percent of beds in metro areas. It has a total bed capacity of over 2,300, with an average revenue per occupied bed (ARPOB) of Rs. 32,395 and an occupancy rate of 65 percent, showing strong performance and quality healthcare services.
Capacity Expansion
After Q2 FY26, Yatharth Hospital & Trauma Care Services Limited plans to significantly expand its bed capacity as part of its greenfield and brownfield projects. The Faridabad facility will operationalize approximately 400 new beds.
The company plans to expand by adding 200–300 beds through greenfield and M&A projects, and 450 beds via brownfield development by FY28. By the end of FY28, the hospital aims to achieve a total bed capacity of around 3,000, reinforcing its position as a leading healthcare provider.
Revenue Mix
Yatharth Hospital & Trauma Care Services Limited has a well-diversified revenue mix across its hospitals for Q1 FY26. The Noida Extension hospital contributes the highest share with 34 percent of the total revenue, followed by Greater Noida at 30 percent.
The Noida hospital adds 20 percent, while Faridabad and Jhansi-Orchha hospitals contribute 9 percent and 7 percent, respectively. This balanced distribution shows that the company’s income comes from multiple locations, reducing dependence on any single hospital.
Recent quarter results
Coming into financial highlights, Yatharth Hospital & Trauma Care Services Limited’s revenue has increased from Rs. 212 crore in Q1 FY25 to Rs. 258 crore in Q1 FY26, which has grown by 21.70 percent. The net profit has also grown by 40 percent from Rs. 30 crore in Q1 FY25 to Rs. 42 crore in Q1 FY26.
Yatharth Hospital & Trauma Care Services Limited’s revenue and net profit have grown at a CAGR of 31.87 percent and 43.86 percent, respectively, over the last five years.
In terms of return ratios, the company’s ROCE and ROE stand at 14 percent and 10.4 percent, respectively. Yatharth Hospital & Trauma Care Services Limited has an earnings per share (EPS) of Rs. 15.2, and its debt-to-equity ratio is 0.01x.
Written By – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
